I am a nuclear medicine physician (MD, PhD) with extensive clinical experience spanning from 2016 to 2024. After earning my medical degree from Hokkaido University, Japan, I completed my internship at Asahikawa Red Cross Hospital, followed by a residency in nuclear medicine and diagnostic radiology at Hokkaido Cancer Center. Subsequently, I served as a clinical fellow in nuclear medicine at Hokkaido University Hospital while concurrently pursuing my doctoral studies at Hokkaido University, where I obtained my Ph.D. in Medicine in 2024.
My research primarily focuses on theranostics and PET imaging, with particular emphasis on the development of novel PET tracers and therapeutic applications. In recognition of my contributions to [131I] MIBG therapy, I was honored with the Gold Award by the Japanese Society of Nuclear Medicine. I have also received multiple accolades, including the Outstanding Presentation Award from the Japan Radiological Society and the Bronze Award at the 10th Hokkaido University Cross-Departmental Symposium.
I hold a medical license in Japan and board certification in diagnostic radiology from the Japan Radiological Society. I am an active member of both the Japan Radiological Society and the Japanese Society of Nuclear Medicine. Through a combination of clinical practice and research, I am committed to contributing to the advancement of nuclear medicine.
I am a nuclear medicine physician (MD, PhD) with extensive clinical experience spanning from 2016 to 2024. After earning my medical degree from Hokkaido University, Japan, I completed my internship at Asahikawa Red Cross Hospital, followed by a residency in nuclear medicine and diagnostic radiology at Hokkaido Cancer Center. Subsequently, I served as a clinical fellow in nuclear medicine at Hokkaido University Hospital while concurrently pursuing my doctoral studies at Hokkaido University, where I obtained my Ph.D. in Medicine in 2024.
My research primarily focuses on theranostics and PET imaging, with particular emphasis on the development of novel PET tracers and therapeutic applications. In recognition of my contributions to [131I] MIBG therapy, I was honored with the Gold Award by the Japanese Society of Nuclear Medicine. I have also received multiple accolades, including the Outstanding Presentation Award from the Japan Radiological Society and the Bronze Award at the 10th Hokkaido University Cross-Departmental Symposium.
I hold a medical license in Japan and board certification in diagnostic radiology from the Japan Radiological Society. I am an active member of both the Japan Radiological Society and the Japanese Society of Nuclear Medicine. Through a combination of clinical practice and research, I am committed to contributing to the advancement of nuclear medicine.